The Pharma Data

MARCH 4, 2021

Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for Dupixent ® (dupilumab) as an add-on treatment for children aged 6 to 11 years with uncontrolled moderate-to-severe asthma. Dupixent is approved in the U.S.

Genetics 52

Genetics Medicine Antibody Trials 52

Druggist

NOVEMBER 6, 2020

Patients commonly request over the counter medicines for a chesty cough. In today’s post, I will seek to find the best medicine for chesty cough by looking at over the counter and pharmacy-only products available in the UK. The best evidence for or against the effectiveness of medicines comes from well designed clinical trials.

Medicine 69

Medicine Containment Pharmacy Production 69

The Pharma Data

FEBRUARY 13, 2022

If approved, Dupixent will be the first biologic medicine available in the U.S. Dupixent remains the only biologic medicine approved for patients 6 years of age and older in this indication. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.

Medicine 40

Medicine Genetics Antibody Allergies 40

Pfizer

JULY 19, 2022

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 Tell your vaccination provider about all of the vaccine recipient’s medical conditions, including if the vaccine recipient: has any allergies. has a fever.

Vaccination 100

Vaccination Vaccine Medicine Clinical Trials 100

The Pharma Data

MARCH 2, 2021

The Company plans to file for a Biologics License Application (BLA) with the FDA later in 2021. The Company will ship the vaccine using the same cold chain technologies it uses today to transport treatments for cancer, immunological disorders and other medicines. Johnson & Johnson’s COVID-19 Vaccine. have a fever.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 12, 2021

Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as in-vivo & in-vitro diagnostics, across many modalities. NEW YORK and LONDON, Jan. He has in depth Global Development Expertise (e.g.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

The Pharma Data

FEBRUARY 12, 2022

Lilly has licensed and developed bebtelovimab after it was discovered by AbCellera and the scientists at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center. is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world.

Antibody 40

Antibody Trials Clinical Trials Clinical Trials 40

Druggist

DECEMBER 9, 2020

Topical steroids are not directly classified as anti-itch medicines; however, it is thought that reduced skin itchiness comes from controlling skin inflammation (ibid). Pharmacy-only medicines can only be purchased from pharmacies, including online chemists. Clobetasone has a narrow licensed use. very potent steroid creams.

Pharmacy 97

Pharmacy Containment Sales Production 97

The Pharma Data

JULY 29, 2021

Tonya Winders, CEO & President, Allergy and Asthma Network (AAN) and President of Global Allergy and Airways Patient Platform (GAAPP) commented: “Patients with chronic rhinosinusitis with nasal polyps experience unpleasant symptoms across a range of severities. It is not currently approved for use in COPD anywhere in the world.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials Trials 52

The Pharma Data

JULY 29, 2021

professor of medicine and co-director of the Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center at Vanderbilt University Medical Center and co-principal investigator of COV-BARRIER. Baricitinib is an oral JAK inhibitor discovered by Incyte and licensed to Lilly. Wesley Ely, M.D., BC HCP EUA ISI 28JUL2021.

HR 52

HR Licensing Licensing FDA Approval 52

Pfizer

SEPTEMBER 28, 2022

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5-Adapted Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5-Adapted 5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age. Tue, 09/27/2022 - 16:15. Wednesday, September 28, 2022 - 11:45am.

Vaccination 101

Vaccination Vaccine Medicine Clinical Trials 101

The Pharma Data

DECEMBER 23, 2020

The lead Principal Investigator for the INNOVATE trial is Dr. Pablo Tebas , Professor of Medicine at the Hospital of the University of Pennsylvania. About INOVIO’s DNA Medicines Platform. INOVIO’s DNA medicines do not interfere with or change in any way an individual’s own DNA.

DNA 40

DNA Vaccination Vaccine Immune Response 40

Druggist

FEBRUARY 3, 2021

Most supermarkets and pharmacies sell their own ‘brands’ of cetirizine, for example, Tesco Allergy and Hayfever Relief 10mg tablets and Lloyds Pharmacy Antihistamine Hayfever Relief 10mg tablets, both produced by the same manufacturer. 240 - 10mg Loratadine One a Day hay fever and Allergy Relief Tablets GSL - 8 months supply.

Allergies 52

Allergies Pharmacy Containment Branding 52

The Pharma Data

DECEMBER 8, 2020

Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the Swiss Federal Government has increased its confirmed order commitment from 4.5 .–(BUSINESS WIRE)–Dec. 8, 2020– Moderna, Inc., million to 7.5

Vaccination 40

Vaccination Vaccine Manufacturing Containment 40

The Pharma Data

MAY 4, 2021

This donation furthers both Lilly and Direct Relief’s charitable goal of providing access to COVID-19 treatments to patients in need by providing these medicines free of charge to low- and lower-middle-income countries. Click here for resources related to Lilly ‘s COVID-19 efforts and here for baricitinib’s EUA.

Antibody 52

Antibody Medicine FDA Approval Licensing 52

Pharmaceutical Technology

JUNE 9, 2023

The FDA accepted nirsevimab’s biologics license application (BLA) in January, with a PDUFA date penned for Q3 2023. However, Dr. Steven King, professor of pediatrics at Northwestern University Feinberg School of Medicine, differed, saying that available data allows for extrapolation here.

FDA Approval 147

FDA Approval Antibody Allergies Packaging 147

The Pharma Data

MAY 18, 2021

This included net special gains of 15 million euros (Q1 2020: net special charges of 639 million euros), with income from a patent dispute related to the blood-clotting medicine Jivi™ more than offsetting the expenses for the ongoing restructuring program. in the Allergy & Cold category. EBIT increased by 23.4 percent to 2.59

Sales 40

Sales Production Marketing Containment 40

The Pharma Data

AUGUST 5, 2021

Earnings were also diminished by a negative product mix, currency effects of 111 million euros, and the later receipt of license revenues. Sales of prescription medicines (Pharmaceuticals) rose by 16.2 and from a strong allergy season in North America, which resulted in a 15.8 in sales in the Allergy & Cold category.

Sales 52

Sales Production Gene Therapy Allergies 52

The Pharma Data

APRIL 16, 2021

“Lilly moved quickly to make bamlanivimab alone available as a potentially lifesaving medicine at a time when Americans were hardest hit by COVID-19,” said Daniel Skovronsky, M.D., However, sites of care should not dispose of bamlanivimab supply; instead, they should order etesevimab to pair with it.

Antibody 52

Antibody Development Medicine Protein 52

The Pharma Data

APRIL 14, 2021

Lilly scientists rapidly developed the antibody in less than three months after it was discovered by AbCellera and the scientists at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center. It was identified from a blood sample taken from one of the first U.S. patients who recovered from COVID-19.

Antibody 52

Antibody Protein Scientist Development 52

Druggist

SEPTEMBER 7, 2020

The second generation of antihistamines , for example, loratadine and cetirizine, which can also be purchased over the counter for the treatment of allergies cross the blood-brain barrier in significantly smaller amounts as compared to the first generation of antihistamines. Both products are pharmacy-only medicines.

Containment 94

Containment Pharmacy Licensing Licensing 94

Drug Discovery World

FEBRUARY 3, 2023

A research group from the National Institutes of Health has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine. SUDV, identified in 1976, is one of the four viruses known to cause human Ebolavirus disease.

Vaccination 52

Vaccination Vaccine Genetic Engineering Protein 52

Druggist

FEBRUARY 17, 2021

Hydrocortisone cream is classified as pharmacy-only medicine (P), which means it can only be sold in pharmacies, including online chemists and sellers on Amazon.co.uk. Anthisan Cream contains a medicine called mepyramine maleate. Lanacane is licensed for adults and children from 12 years of age. Rashes caused by allergies .

Pharmacy 98

Pharmacy Containment Production Sales 98

Scienmag

DECEMBER 17, 2020

December 17, 2020 — An opinion piece published today online in BMJ by Nina Schwalbe in the Heilbrunn Department of Population and Family Health at Columbia Mailman School of Public Health, calls for a national vaccine strategy now that COVID-19 vaccines are available.

Vaccination 40

Vaccination Vaccine Licensing Licensing 40

Pfizer

JANUARY 27, 2023

The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.

Research 112

Research Vaccination Vaccine Drugs 112

The Pharma Data

JULY 8, 2021

Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and granted Priority Review for tezepelumab in the treatment of asthma. Despite recent advances in severe asthma, many patients may not qualify for or respond well to current biologic medicines.(2-5) Ann Allergy Asthma Immunol. Priority Review.

Allergies 52

Allergies Trials In-Vivo Medicine 52

Pfizer

JULY 26, 2022

Emergency uses of the vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID 19) in individuals 6 months of age and older. is immunocompromised or are on a medicine that affects the immune system. has a fever.

Vaccination 111

Vaccination Vaccine Protein Immune Response 111

Druggist

OCTOBER 17, 2020

In the UK, all contraceptive are prescription-only medicines which require a doctor or other qualified prescriber to issue a prescription. Lovima is the first oral contraceptive which has a status or pharmacy-only medicine (P). P medicines are available over the counter from pharmacies or registered online chemists.

Pharmacy 94

Pharmacy Doctors Doctor Containment 94

The Pharma Data

JULY 8, 2021

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration (FDA). Despite recent advances in severe asthma, many patients may not qualify for or respond well to current biologic medicines.

Trials 52

Trials Medicine Sales Clinical Trials 52

Pfizer

JULY 8, 2022

Food and Drug Administration (FDA) approved the companies’ supplemental Biologics License Application (sBLA) for their COVID-19 vaccine, known as COMIRNATY® (COVID-19 Vaccine, mRNA), to include individuals 12 through 15 years of age. Tell your vaccination provider about all of your medical conditions, including if you: have any allergies.

FDA Approval 102

FDA Approval Vaccination Vaccine Clinical Trials 102

Pfizer

JULY 8, 2022

Emergency uses of the vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID 19) in individuals 6 months of age and older. is immunocompromised or is on a medicine that affects the immune system. has a fever.

Vaccination 81

Vaccination Vaccine Clinical Trials Clinical Trials 81

The Pharma Data

NOVEMBER 4, 2020

Progressed European regulatory review and commercial preparations : Continued to support regulatory review of VASCEPA by the European Medicines Agency (EMA) with the expectation of an early 2021 approval of VASCEPA for commercial sale in Europe. In addition, Amarin recognized licensing and royalty revenue of approximately $1.3

Sales 40

Sales Production Cardiology Marketing 40

The Pharma Data

SEPTEMBER 2, 2021

As a global leader in respiratory and allergy, we remain committed to reimagining medicine for patients living with chronic respiratory diseases like asthma.”. GLY certain use and formulation intellectual property were exclusively licensed to Novartis in April 2005 by Sosei Heptares and Vectura. g) and medium-dose (150/50/80?g)

Licensing 52

Licensing Licensing Drug Delivery Allergies 52

Pfizer

SEPTEMBER 16, 2022

Tell your vaccination provider about all of your medical conditions, including if you: have any allergies. are immunocompromised or are on a medicine that affects the immune system. CHMP separately recommends approval of booster dose of COMIRNATY® in children 5 through 11 years of age in the European Union . have a fever.

Marketing 75

Marketing Vaccination Vaccine Clinical Trials 75

The Pharma Data

AUGUST 17, 2021

Do not take Lyumjev or Humalog if you have: symptoms of low blood sugar (hypoglycemia) an allergy to insulin lispro-aabc, Humalog, or any of the ingredients in Lyumjev or Humalog. Also tell your doctor: about all of the medicines you take, including over-the-counter medicines, vitamins, and herbal supplements. Before using.

Insulin 52

Insulin FDA Approval Doctors Doctor 52

The Pharma Data

APRIL 8, 2021

MPH, professor of medicine and co-director of the Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center at Vanderbilt University Medical Center. Baricitinib, an oral JAK inhibitor, was discovered by Incyte and licensed to Lilly. Wesley Ely, M.D., ACTT-2 began in May 2020 and has published results from 1,033 patients.

FDA Approval 52

FDA Approval HR Trials Medicine 52

The Pharma Data

NOVEMBER 9, 2020

9, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive topline results from the Phase 3 NAVIGATOR trial in which the investigational medicine tezepelumab demonstrated a statistically significant reduction in exacerbations compared to placebo in patients with severe asthma. THOUSAND OAKS, Calif. ,

Trials 52

Trials Production Sales Manufacturing 52